Cordlife Group Limited (CLIFF)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 3.52 Million SGD | -27.91% |
| 2022 | 4.88 Million USD | 7.49% |
| 2021 | 4.54 Million SGD | -8.22% |
| 2020 | 4.95 Million SGD | 2.94% |
| 2019 | 4.81 Million SGD | 170.87% |
| 2018 | 1.77 Million SGD | -45.7% |
| 2017 | 3.27 Million SGD | 227.22% |
| 2016 | -2.57 Million SGD | -120.86% |
| 2015 | 12.32 Million SGD | -48.86% |
| 2014 | 24.1 Million SGD | -21.02% |
| 2013 | 30.52 Million SGD | 126.35% |
| 2012 | 13.48 Million SGD | 94.69% |
| 2011 | 6.92 Million SGD | -18.29% |
| 2010 | 8.47 Million SGD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q4 | 1.48 Million USD | 213.44% |
| 2023 Q1 | 835.95 Thousand SGD | -72.08% |
| 2023 FY | 3.52 Million SGD | -27.91% |
| 2023 Q2 | 2.22 Million USD | 166.16% |
| 2023 Q3 | 474.73 Thousand SGD | -78.66% |
| 2022 Q1 | 698.36 Thousand SGD | -80.82% |
| 2022 Q2 | 1.89 Million USD | 171.06% |
| 2022 Q3 | 1.04 Million SGD | -44.94% |
| 2022 FY | 4.88 Million USD | 7.49% |
| 2022 Q4 | 2.99 Million USD | 187.24% |
| 2021 Q4 | 3.64 Million SGD | 171.51% |
| 2021 Q3 | 1.34 Million SGD | -46.17% |
| 2021 FY | 4.54 Million SGD | -8.22% |
| 2021 Q1 | 926.3 Thousand SGD | -76.33% |
| 2021 Q2 | 2.49 Million SGD | 169.03% |
| 2020 Q1 | 926.28 Thousand SGD | -74.96% |
| 2020 Q4 | 3.91 Million SGD | 173.02% |
| 2020 FY | 4.95 Million SGD | 2.94% |
| 2020 Q3 | 1.43 Million SGD | -45.55% |
| 2020 Q2 | 2.63 Million SGD | 184.25% |
| 2019 Q1 | 940 Thousand SGD | 843.42% |
| 2019 FY | 4.81 Million SGD | 170.87% |
| 2019 Q4 | 3.69 Million SGD | 210.32% |
| 2019 Q3 | 1.19 Million SGD | 137.92% |
| 2019 Q2 | 501 Thousand SGD | -46.7% |
| 2018 Q3 | 476 Thousand SGD | -54.41% |
| 2018 Q2 | 1.04 Million SGD | 23.84% |
| 2018 Q4 | -126.44 Thousand SGD | -126.56% |
| 2018 FY | 1.77 Million SGD | -45.7% |
| 2018 Q1 | 843 Thousand SGD | 14.54% |
| 2017 Q2 | 678 Thousand SGD | 269.08% |
| 2017 Q3 | 649 Thousand SGD | -4.28% |
| 2017 FY | 3.27 Million SGD | 227.22% |
| 2017 Q1 | -401 Thousand SGD | 82.37% |
| 2017 Q4 | 736 Thousand SGD | 13.41% |
| 2016 Q4 | -2.27 Million SGD | -296.34% |
| 2016 Q2 | -2.5 Million SGD | -22.56% |
| 2016 FY | -2.57 Million SGD | -120.86% |
| 2016 Q1 | -2.04 Million SGD | -121.24% |
| 2016 Q3 | -574 Thousand SGD | 77.08% |
| 2015 Q1 | 18.14 Million SGD | 699.74% |
| 2015 Q4 | 9.62 Million SGD | 32.58% |
| 2015 Q3 | 7.25 Million SGD | -65.12% |
| 2015 Q2 | 20.8 Million SGD | 14.68% |
| 2015 FY | 12.32 Million SGD | -48.86% |
| 2014 FY | 24.1 Million SGD | -21.02% |
| 2014 Q4 | -3.02 Million SGD | 12.62% |
| 2014 Q3 | -3.46 Million SGD | -121.52% |
| 2014 Q2 | 16.08 Million SGD | 952.75% |
| 2014 Q1 | 1.52 Million SGD | -63.97% |
| 2013 Q1 | 1.22 Million SGD | -78.23% |
| 2013 FY | 30.52 Million SGD | 126.35% |
| 2013 Q3 | 8.66 Million SGD | 127.16% |
| 2013 Q2 | 3.81 Million SGD | 210.67% |
| 2013 Q4 | 4.24 Million SGD | -51.06% |
| 2012 Q1 | 832 Thousand SGD | -56.82% |
| 2012 FY | 13.48 Million SGD | 94.69% |
| 2012 Q2 | 2.31 Million SGD | 177.88% |
| 2012 Q3 | 2.8 Million SGD | 21.11% |
| 2012 Q4 | 5.64 Million SGD | 101.46% |
| 2011 Q4 | 1.92 Million SGD | 3.88% |
| 2011 Q2 | 2.29 Million SGD | 18.21% |
| 2011 Q1 | 1.93 Million SGD | 0.0% |
| 2011 FY | 6.92 Million SGD | -18.29% |
| 2011 Q3 | 1.85 Million SGD | -19.03% |
| 2010 FY | 8.47 Million SGD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | 349.858% |
| Arrayit Corporation | -3.31 Million USD | 206.255% |
| Atlantic International Corp. | -5.62 Million USD | 162.602% |
| Biocept, Inc. | -32.08 Million USD | 110.98% |
| Bioqual, Inc. | 483.48 Thousand USD | -628.674% |
| CardioGenics Holdings Inc | -1.91 Million USD | 283.842% |
| DermTech, Inc. | -100.88 Million USD | 103.492% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 99.826% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 116.314% |
| iMD Companies, Inc. | -200.63 Thousand USD | 1855.916% |
| IDenta Corp. | 14.64 Thousand USD | -23957.635% |
| Interpace Biosciences, Inc. | 802 Thousand USD | -339.277% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | -9005.947% |
| InVitro International | 1553.00 USD | -226751.256% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 141.003% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 6162.431% |
| Medical Imaging Corp. | -3.02 Million USD | 216.539% |
| NovelStem International Corp. | -4.18 Million USD | 184.135% |
| Optigenex Inc. | -2.89 Million USD | 221.577% |
| PharmChem, Inc. | 845.1 Thousand USD | -316.873% |
| Proteome Sciences plc | -2.44 Million USD | 244.208% |
| Response Genetics, Inc | -20.18 Million USD | 117.454% |
| Rennova Health, Inc. | -3.29 Million USD | 206.983% |
| RushNet, Inc. | -607.02 Thousand USD | 680.369% |
| ScreenPro Security Inc. | -2.24 Million USD | 256.664% |
| Stella Diagnostics Inc. | -5.7 Million USD | 161.727% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 130.862% |
| Todos Medical Ltd. | -24.99 Million USD | 114.095% |